Laser still the mainstay of macular oedema treatment
The parameters of laser photocoagulation have evolved in recent clinical studies


Dermot McGrath
Published: Monday, June 12, 2017

David Pelayes MD
Clinical trials have demonstrated that lower energy can reduce side effects and risks while effectively alleviating DMEThe general macular settings for the laser now include an exposure time of 10 to 20 milliseconds, resulting in sharply decreased energy density and thermal diffusion, he explained. "Furthermore, studies have shown that the retinal photocoagulation induced by 10 to 30 ms exposure time can stimulate inner retinal healing responses and is associated with less destructive effects than traditional methods," he said.
Tags: macular oedema, retina
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.